Edelman Joseph's Form 4 filing
Acrivon Therapeutics, Inc. (ACRV) · filed May 1, 2025
- Accession no.
- 0001062993-25-008341
- Filed
- May 1, 2025, 7:07 PM ET
- Trade date
- Apr 30-May 1, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.02M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | Common Stock | SSaleDisposed | −437,881 | $1.41 | −$617,412.21 | 3,403,025 | Indirect | |
| May 1, 2025 | Common Stock | SSaleDisposed | −298,886 | $1.34 | −$400,507.24 | 3,104,139 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.